THE RELEVANCE OF ARTHRITIS RESEARCH IN NON-HUMAN PRIMATES
A models are an essential tool in the systematic which are kept at the Biomedical Primate Research Centre in Rijswijk ( The Netherlands), spontaneous dissection of immune and inflammatory pathways which contribute to the development and maintenance manifestations of arthritis are only rarely observed. The animals are kept under much cleaner conditions of arthritis. The majority of animal studies are carried out in rodents for historical and economic reasons.
than in the wild, reflecting the fact that strict veterinary care keeps them free of most pathogens. This supports Here we discuss the contribution which studies of nonhuman primates can make to our understanding of the concept that the inciting event in RA may be associated with exposure of genetically susceptible arthritic processes in humans, together with an appraisal of their potential in evaluating therapies.
individuals to infectious pathogens. The evolutionary distance between the genomes of The aetiology of rheumatoid arthritis (RA) is regarded as being immune mediated with T lymphoman and common laboratory primate species like the rhesus or cynomolgus macaques is estimated at 35 cytes having an important regulatory function [1] . The first step in an antigen-specific immune response is million years, whereas between humans and rodents it is~80 million years. This has obvious implications represented by the formation of a trimolecular complex, consisting of an antigenic peptide (epitope) comfor the similarity of the immune systems between primate species. Allelic lineages are related families of plexed with an MHC molecule on the surface of an antigen-presenting cell (APC ). This is in turn recogalleles which have maintained their genetic identity despite continued accumulation of mutations within a nized by an antigen-specific receptor on the responding T cells ( TCR) [2] . This antigen-specific interaction is species. The presence of similar MHC-DR and MHC-DQ allelic lineages in humans and macaques has been stabilized by bridges between accessory molecules which may also transduce essential stimulatory signals, well documented (reviewed in [11] ) and is of interest because both loci have been implicated as major regusuch as CD4 with MHC class II molecules, CD8 with MHC class I molecules, CD40 with CD40-ligand, latory elements of susceptibility to RA in the human population [5] . CD28 with CD80/86, LFA-1 with ICAM-1, etc. [3] .
How the T lymphocytes are activated in RA and by In humans, three subgroups of class II MHC genes giving rise to functional products are recognized. These which antigen is not known. One possibility is that they respond to antigens derived from infectious pathoare DR, DQ and DP. The MHC-DQA1 and -DQB1 genes in primates exhibit extensive polymorphism. To gens which resemble antigens in the joint (molecular mimicry). In individuals with a certain genetic backdate, 78 non-human primate MHC-DQA and 104 -DQB sequences have been documented. At least three ground, the autoreactive T cells may induce a cascade of reactions leading to RA. In genetic epidemiological lineages are common to humans, chimpanzees and macaques. In general, HLA-DQA2/DQB2 genes studies, the risk for humans of developing RA has been linked to the possession of certain MHC alleles, display only limited polymorphism. In all primate species that have been investigated in particular HLA-DR1 and -DR4 [4] . However, these associations are relatively weak and have been chalthus far, the MHC-DRA locus is invariant. Although humans, chimpanzees and macaques share many linlenged by the observation that the actual risk element for RA may be a HLA-DQ8 molecule binding a eages at the MHC-DR loci, most alleles tend to be species specific. The MHC-DRB1*03, -DRB1*04 and conserved motif in one of the variable regions of the HLA-DR chain [5] . This motif is possibly closely -DRB1*10 lineages are at least 35 million years old. It has now been well established that some MHC-DR3 associated with or identical to the 'shared epitope' [6 ] .
Non-human primates are known to be susceptible lineage members in humans, chimpanzees and macaques select the same epitopes from antigens like to many of the arthritic diseases that affect the human population. They are the most closely related relatives mycobacterial PPD or bovine myelin basic protein, and can even present them to T-cell clones of the other of man and, therefore, of interest as models of human diseases. Spontaneous manifestation of spondylospecies [12] [13] [14] [15] . This observation not only demonstrates the evolutionary conservation of certain allelic arthropathies and osteoarthritis has been documented in apes and Old World monkey species [7] [8] [9] [10] .
lineages and their peptide-binding capacities, but also points to the co-evolution of MHC and TCR gene Susceptibility to spondyloarthropathies shows considerable variation among primate species, namely 1-4%
repertoires. A comparative analysis of TCR b-chain structure and usage in humans, chimpanzees and in humans, 2-3% in Old World monkeys and 20-30% in the great apes (chimpanzee and gorilla), with the macaques has revealed that their genomic and expressed repertoires do not differ substantially exception of orang-utans. Remarkably, in two large outbred populations of chimpanzees (>100 indi-(reviewed in [11] ). MHC-typed colonies of chimpanzees and macaques viduals) and rhesus macaques (>1000 individuals), thus provide a unique setting to investigate in a langeal and metacarpophalangeal joints of hands and feet and in wrists and ankles. In the more advanced controlled ( laboratory) setting the activation of immunopathological pathways that lead to arthritis in stages of CIA, inflammation is also found in tarsal and carpal joints. The individual susceptibilities to CIA of randomly emulsion of fibrin in complete Freund's adjuvant, followed by intra-articular challenge injection of fibrin selected rhesus monkeys from an outbred population vary considerably. Importantly, the different mani-4 weeks later [20] . Collagen-induced arthritis (CIA) is a generally accepted model for human RA in rodents festations of CIA could be associated with genetic and immunological parameters. To date, no association which can also be induced in Old World monkey species [21, 22] . CIA has also been successfully estabbetween CIA susceptibility and any MHC class II allele has been found. However, monkeys in which lished in squirrel monkeys (Saimiri sciureus), while cebus monkeys (Cebus albifrons) were found to be CIA cannot be induced share the same serologically defined MHC class I allele Mamu-A26 [31], which is resistant [23] . The two closely related macaque species cynomolgus monkeys (Macaca fascicularis) [24] and actually an HLA-B locus equivalent. The resistance defined by Mamu-A26 is specific for CIA, segregates rhesus monkeys (Macaca mulatta) [25] are both susceptible to CIA. Surprisingly, a sex bias has only been as a dominant trait in families, and seems to be independent of the MHC class II background of the found in M. fascicularis [24, 26 ] . We have been unable to induce other forms of arthritis in rhesus monkeys, monkey. The resistance to CIA may be associated with the reduced capacity of Mamu-A26-positive monkeys such as with bacterial antigens that have proved arthritogenic in susceptible rat strains [27] . Finally, it to produce anti-C-II antibodies of the IgM isotype. The production of IgG autoantibodies was comparable has been reported that intra-articular injection of methylated bovine serum albumin (BSA) into BSAin responder and non-responder monkeys [32] . More recently, the critical role of IgM autoantibodies in the sensitized marmoset monkeys (Callithrix jacchus) induces a chronic synovitis [28] .
induction of CIA was confirmed [33] . Analysis of the reactivity of sera from arthritic monkeys showed no Collagen-induced arthritis can be induced in rhesus monkeys by a single intradermal injection of heterologconsistent recognition patterns with cyanogen bromide fragments of the collagen molecule [24] or with overous type II collagen (C-II; usually bovine) in complete Freund's adjuvant. Susceptible monkeys develop a lapping 15mer peptides from the major arthritogenic CB11 fragment [34] . polyarthritis, which is mainly expressed as a symmetrical inflammatory swelling of the proximal interpha-
The protection of monkeys from CIA by cyclosporin DRB1 be the protective locus in rheumatoid arthritis?
A treatment points to involvement of T cells in the 
STANDARDS OF CARE FOR ARTHRITIS: POINTING THE WAY FORWARD
L November, the British League Against Rheumaies use different benchmarks for their quality specifications for rheumatology services, resulting in regional tism (BLAR) [1] introduced the UK's first ever nationally agreed standards of care for arthritis with the differences in the quality they require [7] . launch of its report 'Standards of care-towards meeting people's needs' [2] . The launch was the culmination SETTING THE STANDARDS of a lengthy project, funded by the Department of A multi-disciplinary advisory group was set up, Health and involving input from a range of profescomprising representatives from all the major organizasional and patient groups.
tions whose area of interest lay in each of the categories that the standards would cover, namely: Arthritis THE NEED FOR NATIONALLY AGREED Care, the British Society for Rheumatology, the STANDARDS British Society for Rehabilitation Medicine, British Health Professionals in Rheumatology, the British In 1994, BLAR published 'Disability and arthritis' [3], which reported the results of a survey of almost Orthopaedic Association, the Disability Living Allowance Advisory Board, the Primary Care 500 people with arthritis across the UK. Although it is universally recognized that a high quality arthritis Rheumatology Society and the Royal College of Nursing Rheumatology Nursing Forum. The standards service requires input from a multi-disciplinary team, the report showed that most people surveyed received were set by the advisory group using a modified Delphi method [8] to achieve consensus views. 'Essential' and care wholly from their GP or a hospital-based rheumatologist; only a small proportion received input from 'desirable' standards were set for both osteo-and rheumatoid arthritis; the essential standards represother health professionals [3] .
The Patient's Charter [4] promotes standards of care enting the minimum service provision, whilst the desirable represent an ideal level. for the general UK population and national standards of care exist for other conditions such as diabetes [5] The standards do not concern issues such as waiting times (which are covered in the Patient's Charter [4] ), and back pain [6 ] . In the absence of nationally agreed standards of care for arthritis, commissioning authoritnor do they deal with how an individual's arthritis should be managed medically, as appropriate guiderange of multi-disciplinary services, but for a greater awareness among people with arthritis of how these lines also exist [9, 10]. They do, however, reflect the philosophy of meeting the growing demand by patients services are involved in the care of the disease. Critics may claim that such measures will raise patient expectafor information about illness and the services that can play a part in care [11] . The full list of standards and tions unfairly, but BLAR takes the view that it is only through discussion and explanation that people will the condition to which they apply are shown in the appendix.
come to understand what can and cannot be achieved in relation to their arthritis. Evidence suggests that AUDITING THE STANDARDS people with arthritis have different views as to the cause and nature of their illnesses than their doctors The project also aimed to discover how well care for people with arthritis in the UK measured up to the [12, 13] , and BLAR hopes the provision of information called for in the standards of care will help address standards. A nationwide questionnaire audit was conducted involving 18 regions in the UK and over 1000 this problem. Whilst BLAR has no specific evidence that meeting people with arthritis. In brief, the main findings are as listed below. these standards will improve the medical outcome of people with arthritis, there is an increasing body of evidence to suggest that information about, and greater
Primary care
Almost all respondents said they had discussed the understanding of, chronic illness can improve outcome. Within rheumatology, a great deal of evidence has nature of their arthritis with their GP, and over threequarters said that their GP had examined their joints.
been compiled suggesting a complex relationship between information/education and outcomes such as Primary care also fared well in providing explanations concerning certain medication. However, in terms of pain reduction, increased exercise behaviour, improved psychological status and coping skills, improved providing explanations about other possible treatments and services, and in providing written information, the doctor-patient communication and reduced use of health services [14] . Most of the standards of care situation was less flattering.
reflect this philosophy of supporting people with arthritis through education and awareness, and BLAR
Rheumatology secondary care
Rheumatology departments had discussed the kind believes that through meeting the standards, the lives of people with arthritis will be improved irrespective of arthritis people had with over three-quarters of respondents. As in primary care, they also fared relaof medical advances. tively well in providing discussions of the various POINTING THE WAY FORWARD arthritic medication. However, like primary care there also existed a shortfall in providing information, both In today's health care climate of audit, clinical effectiveness and increased public accountability, the verbal and written, about other aspects of treatment and care.
aim of ensuring the quality of the entire care experience has never been more explicitly stated and there has been a trend towards developing national standards of Orthopaedic secondary care
It seems that orthopaedic departments fared much care and good practice in many different specialities across the globe [15-18]. We hope that the multibetter in providing the recommended verbal explanations, and in providing advice about returning home disciplinary approach to developing standards that has been outlined above will be utilized internationally, after an operation, but the provision of written information was another area of concern, particularly and we look forward to the development of standards for arthritis from the wider rheumatology community. for the respondents with osteoarthritis. Of those respondents requiring an orthopaedic operation, over
As for the UK, BLAR believes that the way forward in the care of arthritis is for its standards to become a quarter had not received any relevant literature.
the benchmark of the level of quality required by commissioners of rheumatology services. To this end,
In-patient care and X-rays
The findings regarding standards for in-patient care, BLAR is attempting to persuade health authorities/ commissioners to incorporate the BLAR standards including orthopaedic in-patient care, are very encouraging. Very high proportions of respondents reported into their contract or service specifications for rheumatology services: commissioners who already have that all of the relevant standards had been met. Also encouraging was the finding that only a small percentspecific quality standards for rheumatology services could do this quite easily. Ultimately, however, the age of those having an X-ray experienced discomfort in joints other than those being X-rayed.
only way such standards will be implemented is through the cooperation of rheumatology service staff WHAT THE STANDARDS CAN ACHIEVE and therefore over the last 4 months, the 'Standards of care' report has been distributed to every rheumatoThe purpose of the audit was not to criticize, but to highlight where improvements could and should be logy department in the UK. The standards are comprehensive, yet flexible made. The standards should be considered a challenge to the services involved rather than a threat. BLAR is enough to allow the multitude of individual care approaches to flourish. A unique feature of the BLAR not calling for widespread increases in referrals to a 20. NHS Confederation. Patients influencing purchasers. standards is that they were devised through patient NHS Confederation, 1997. and multi-disciplinary professional group collaboration. In the UK in particular, it seems likely that such a philosophy will have a major role in the future of the health service [19, 20] . Therefore, as we approach APPENDIX: THE BLAR STANDARDS OF CARE the next millennium the importance of these standards FOR OSTEOARTHRITIS (OA) AND for rheumatology should be recognized, and accord-RHEUMATOID ARTHRITIS (RA) ingly, they should be truly considered to point the way forward in the care of people with arthritis. 
